Pakistan to launch new type of nasal Coronavirus vaccine protocol
ISLAMABAD: With only four million people having been fully or partially vaccinated across the country, the University of Health Sciences (UHS) has started working on protocols to start trials for nasal Covid-19 vaccine.
It will be a single dose vaccine, which does not require a syringe. It is hoped the clinical trial will commence in six to eight weeks after approval from three committees is obtained.
On the other hand, the country reported 3,060 new cases and 57 deaths in a single day.
Talking to *Dawn*, UHS Vice Chancellor Dr Javed Akram said the university had started developing protocols for the clinical trial of the nasal vaccine.
“The vaccine will be single dose and has been manufactured by the Cansino Biologics whose single dose injectable vaccine is already being used in Pakistan. Nasal vaccines are usually given to children but there will be no age limit for it and it can be administered to both children and adults,” he said.